One Trelegy Ellipta inhaler lasts 30 days. Here is what it costs in eight places, from official price lists — and what patients actually pay.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Trelegy Ellipta 100/62.5/25 mcg (US labelling) — the same product is labelled 92/55/22 mcg in Europe, which states the dose leaving the mouthpiece. One inhaler holds 30 doses, taken once a day, so 30 days = one inhaler. Each country’s own official price; US dollars at European Central Bank reference rates of November 5, 2026. The price types differ — list price, negotiated price, pharmacy acquisition cost, retail price — and are labelled.
TRELEGY ELLIPTA · 30 DAYS = ONE INHALER (30 DOSES)
Price by country, November 2026
US pharmacy cost: CMS prices per blister × 60 blisters per inhaler (our calculation). Germany has no statutory price ceiling for Trelegy.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (pharmacy cost) | $11.15189 per blister; one inhaler = 60 blisters (two strips of 30) (CMS NADAC, Nov 4, 2026) | $669 | Depends on insurance |
| 🇺🇸 United States (list, 2024) | $654 per 30-day supply, 2024 list price (wholesale acquisition cost, CMS) | $654 | — |
| 🇺🇸 United States (Medicare, 2027) | $175 negotiated price per 30-day supply, from Jan 1, 2027 (CMS) | $175 | Depends on the Part D plan |
| 🇬🇧 United Kingdom | £44.50 per inhaler (NHS price, since Nov 22, 2017) | $60 | £9.90 per item in England; free in Scotland, Wales and Northern Ireland |
| 🇫🇷 France | €48.59 per inhaler (official price excluding dispensing fee) | $55 | 70% of the price unless a complementary insurer covers it (30% reimbursed, for severe COPD in adults) |
| 🇨🇭 Switzerland | CHF 76.80 per inhaler (public price) | $94 | 10% share after the annual deductible |
| 🇦🇹 Austria | €69.45 per inhaler (social-insurance price excl. VAT; effective price may be lower under a price model) | $78 | €7.55 prescription fee per pack; reimbursed for the listed indications |
| 🇳🇱 Netherlands | €54.45 per inhaler (average pharmacy price) | $61 | Fully reimbursed; counts toward the annual deductible |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag) for this combination | — | €5–€10 co-payment per pack (10%, min. €5, max. €10) |
We compare prices; we do not recommend where to buy medicine. Whether to start or switch an inhaler is a decision for your doctor.
The $669 is what US pharmacies paid on average to buy one inhaler in late October and early November 2026 (NADAC); CMS prices Trelegy per blister, and one inhaler has two strips of 30 blisters, according to the FDA label. The $654 is the 2024 list price that CMS used for its comparison; GSK does not publish a current list price on its US sites. The $175 is the price Medicare negotiated under the Inflation Reduction Act for a 30-day supply. It applies from January 1, 2027; pharmacies that dispense to Medicare patients are refunded the difference by the drug maker afterwards (CMS).
In 2024, about 1.27 million people with Medicare Part D used Trelegy, and Part D spent $5.3 billion on it before rebates — second only to the Ozempic, Rybelsus and Wegovy group among the 15 drugs in the 2027 round (CMS).
France, the UK, the Netherlands, Austria and Switzerland publish an official price for the same inhaler — about $55 to $94 at ECB rates. That is 8% to 14% of what US pharmacies pay (our calculation: $55 ÷ $669 and $94 ÷ $669). Germany has no statutory price ceiling for Trelegy and no freely published official pharmacy price; insured patients pay the usual co-payment of 10% of the price, at least €5 and at most €10 per pack. From 2027 the limits rise to €7.50 and €15.
US pharmacies paid about $669 for one 30-dose Trelegy Ellipta inhaler in November 2026 (CMS NADAC). Medicare’s negotiated price from January 1, 2027 is $175 for a 30-day supply (CMS). Official prices for the same inhaler: £44.50 in the UK, €48.59 in France, €54.45 in the Netherlands, €69.45 in Austria (excl. VAT) and CHF 76.80 in Switzerland — about $55 to $94 at ECB rates.
CMS negotiated $175 for a 30-day supply, effective January 1, 2027 — 73% below the 2024 list price of $654. What a Medicare patient pays still depends on the Part D plan.
In England each prescription item costs £9.90 (free in Scotland, Wales and Northern Ireland). France reimburses 30% of the official price, for severe COPD in adults. In Switzerland insured patients pay a 10% share after the annual deductible; in Austria a €7.55 prescription fee; in the Netherlands it is fully reimbursed but counts toward the annual deductible. In Germany the co-payment is 10% of the price, at least €5 and at most €10 per pack.
Not that we found: the US national pharmacy price survey (NADAC, November 4, 2026) and the UK’s dm+d list only the GSK product.
CMS prices Trelegy Ellipta per blister. One inhaler contains two foil strips of 30 blisters each (FDA label), so the inhaler price is the blister price × 60 (our calculation). One inhaler still gives 30 daily doses.
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
